Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hilfiker

Showing results (641-650 of 743) with videos related to

Pageof 75
Sort By:
The Journal of Clinical Investigation|April 27, 2013
MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathyJulie Halkein, Sebastien P Tabruyn, Melanie Ricke-Hoch, et al.
Environmental Science: Atmospheres|February 6, 2023
Effect of OH scavengers on the chemical composition of α-pinene secondary organic aerosolDavid M Bell, Veronika Pospisilova, Felipe Lopez-Hilfiker, et al.
Cardiovascular Research|June 22, 2014
Expression of fibulin-6 in failing hearts and its role for cardiac fibroblast migrationArpita Chowdhury, Christine Herzog, Lisa Hasselbach, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 20, 2025
Mycobacterium tuberculosis Infection and Acute or Subclinical Coronary Artery Disease: the Swiss HIV Cohort StudyAnina Hilfiker, Isabella C Schoepf, Emma F Avery, et al.
Bioorganic & Medicinal Chemistry Letters|April 26, 2011
Structure-activity relationship studies of novel 3-oxazolidinedione-6-naphthyl-2-pyridinones as potent and orally bioavailable EP3 receptor antagonistsÁngel I Morales-Ramos, Yue H Li, Mark Hilfiker, et al.
European Journal of Heart Failure|July 14, 2025
Immune dysregulation as a key driver of peripartum cardiomyopathy - an exploratory advanced imaging and biomarker studyJulian Hoevelmann, Charle Viljoen, Tessa Kotze, et al.
Journal of the American College of Cardiology|January 29, 2011
Nebivolol exerts beneficial effects on endothelial function, early endothelial progenitor cells, myocardial neovascularization, and left ventricular dysfunction early after myocardial infarction beyond conventional β1-blockadeSajoscha A Sorrentino, Carola Doerries, Costantina Manes, et al.
Cardiovascular Research|June 19, 2018
Metabolic changes in hypertrophic cardiomyopathies: scientific update from the Working Group of Myocardial Function of the European Society of CardiologyJolanda van der Velden, Carlo G Tocchetti, Gilda Varricchi, et al.
Journal of Cellular and Molecular Medicine|January 9, 2019
Electrophysiological abnormalities in induced pluripotent stem cell-derived cardiomyocytes generated from Duchenne muscular dystrophy patientsBinyamin Eisen, Ronen Ben Jehuda, Ashley J Cuttitta, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 10, 2017
Risk for life-threatening arrhythmia in newly diagnosed peripartum cardiomyopathy with low ejection fraction: a German multi-centre analysisDavid Duncker, Ralf Westenfeld, Torsten Konrad, et al.
Pageof 75

Showing results (641-650 of 743) with videos related to

Sort By:
Pageof 75
The Journal of Clinical Investigation|April 27, 2013
MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathyJulie Halkein, Sebastien P Tabruyn, Melanie Ricke-Hoch, et al.
Environmental Science: Atmospheres|February 6, 2023
Effect of OH scavengers on the chemical composition of α-pinene secondary organic aerosolDavid M Bell, Veronika Pospisilova, Felipe Lopez-Hilfiker, et al.
Cardiovascular Research|June 22, 2014
Expression of fibulin-6 in failing hearts and its role for cardiac fibroblast migrationArpita Chowdhury, Christine Herzog, Lisa Hasselbach, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 20, 2025
Mycobacterium tuberculosis Infection and Acute or Subclinical Coronary Artery Disease: the Swiss HIV Cohort StudyAnina Hilfiker, Isabella C Schoepf, Emma F Avery, et al.
Bioorganic & Medicinal Chemistry Letters|April 26, 2011
Structure-activity relationship studies of novel 3-oxazolidinedione-6-naphthyl-2-pyridinones as potent and orally bioavailable EP3 receptor antagonistsÁngel I Morales-Ramos, Yue H Li, Mark Hilfiker, et al.
European Journal of Heart Failure|July 14, 2025
Immune dysregulation as a key driver of peripartum cardiomyopathy - an exploratory advanced imaging and biomarker studyJulian Hoevelmann, Charle Viljoen, Tessa Kotze, et al.
Journal of the American College of Cardiology|January 29, 2011
Nebivolol exerts beneficial effects on endothelial function, early endothelial progenitor cells, myocardial neovascularization, and left ventricular dysfunction early after myocardial infarction beyond conventional β1-blockadeSajoscha A Sorrentino, Carola Doerries, Costantina Manes, et al.
Cardiovascular Research|June 19, 2018
Metabolic changes in hypertrophic cardiomyopathies: scientific update from the Working Group of Myocardial Function of the European Society of CardiologyJolanda van der Velden, Carlo G Tocchetti, Gilda Varricchi, et al.
Journal of Cellular and Molecular Medicine|January 9, 2019
Electrophysiological abnormalities in induced pluripotent stem cell-derived cardiomyocytes generated from Duchenne muscular dystrophy patientsBinyamin Eisen, Ronen Ben Jehuda, Ashley J Cuttitta, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 10, 2017
Risk for life-threatening arrhythmia in newly diagnosed peripartum cardiomyopathy with low ejection fraction: a German multi-centre analysisDavid Duncker, Ralf Westenfeld, Torsten Konrad, et al.
Pageof 75